Big Market Research has added a report, titled Global Deep Brain Stimulation Market Professional Survey Report 2016. The report offers in-depth insights into profile of key players, current market dynamics, recent technological advances, emerging application segments, and lucrative avenues along with growth prospects of the players across regions. The global market for DBS devices is driven by the high incidence of psychiatric & neurological disorders, rising awareness over available therapies, increase in treatment indications, growing R&D investments, and recent technology enhancements.
The adoption of modern equipment in healthcare infrastructure coupled with growing expertise of surgeons in using DBS are the key factors boosting the market growth across advanced regions. The device has revolutionized the treatment of certain neurological diseases, such as Parkinsons disease, dystonia, and essential tremor. Market players are actively launching novel solutions and treatment therapies; this will create new growth opportunities in the market. Deep brain stimulation (DBS) is a surgical procedure to treat a range of neurological symptoms that cannot be controlled by medication. Most common conditions treated by DBS device are debilitating symptoms of Parkinsons disease (PD), such as rigidity, stiffness, tremor, and walking problems.
Enquire about report @ http://www.bigmarketresearch.com/report-enquiry/575035
Medical device manufacturers have made significant performance and efficacy improvements to expand the applications of DBS. The study provides considerable insights into the emerging applications trends in healthcare sector. Insights into market estimates and projections of the segments are offered in the analysis.
A detailed quantitative insight is offered by covering revenue shares and size of key companies, production volumes & capacity of various manufactures, import/export figures of key products, market size of key segments, and growth avenues of segments across various regions. The study offers SWOT analysis of companies to assess the bargaining power of buyers and suppliers. An incisive analysis of the emerging segments covers the industry chain developmental factors along with the market impact of recent partnerships on growth prospects.
The analysis is useful to key stakeholders, market participants, and investors to gain an insight into crucial factors that affect key market dynamics; the measures taken by top vendors to add value across industry chain are also covered. Recent advances in functional neuroanatomy, neuroimaging, and neurophysiology are likely to unlock new growth opportunities in the market.
Major manufacturers who are extensively profiled in the report include Boston Scientific Corp, Medtronic plc. St. Jude Medical Inc., Adaptive Neuromodulation, Aleva Neurotherapeutics, Beijing Pins Medical, NeuroPace and NeuroSigma.
The study takes a closer look at recent clinical studies, and offers a critical evaluation of new projects and ventures on market growth. The analysis is immensely useful to investors, business planners & executives, market participants, and key stakeholders to gain a better understanding of the market.
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
Direct: + 1-503-894-6022
Toll Free: + 1-800-910-6452
Fax: +1 (855) 5505975